Evidence map›Paper›PMID 33114715›Full record

ArticleAntibiotics (Basel, Switzerland)2020

The Clinical Need for New Diagnostics in the Identification and Management of Patients with Suspected Sepsis in UK NHS Hospitals: A Survey of Healthcare Professionals.

Amanda Winter, William Stephen Jones, A Joy Allen, D Ashley Price, Anthony Rostron, Raffaele Filieri, Sara Graziadio

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Amanda WinterNIHR Newcastle In Vitro Diagnostics Co-Operative, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
William Stephen JonesTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
A Joy AllenNIHR Newcastle In Vitro Diagnostics Co-Operative, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0002-3222-0396
D Ashley PriceThe Newcastle Hospitals NHS Foundation Trust, Royal Victoria Infirmary, Queen Victoria Road, Newcastle Upon Tyne NE1 4LP, UK.
Anthony RostronTranslational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.ORCID 0000-0002-9336-1723
Raffaele FilieriAudencia Business School, Marketing Department, 8 Route de la Jonelière, B.P. 31222, 44312 Nantes, CEDEX 3, France.ORCID 0000-0002-3534-8547
Sara GraziadioNIHR Newcastle In Vitro Diagnostics Co-Operative, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.
Royal Victoria Infirmary · GBAudencia Business School · FRNewcastle University · GBNIHR Leeds In Vitro Diagnostics Co-operative · GBSunderland Royal Hospital · GB

Funding

Innovate UK 82371-510474
6 · The paper itself

Abstract

Development of a new diagnostic is ideally driven by an understanding of the clinical need that the test addresses and the optimal role the test will have within a care pathway. This survey aimed to understand the clinical need for new sepsis diagnostics and to identify specific clinical scenarios that could be improved by testing. An electronic, cross-sectional survey was circulated to UK National Health Service (NHS) doctors and nurses who care for patients with suspected sepsis in hospitals. Two hundred and sixty-five participants completed the survey, representing 64 NHS Trusts in England. Sixty-seven percent of respondents suggested that the major cause of delay was during the initial identification of sepsis and the subsequent recognition of patients who were deteriorating. Existing blood tests did not enhance the confidence of consultants making their diagnoses. Those surveyed identified a role for a near-patient test to "rule out" suspected sepsis and, thereby, stop or postpone use of antibiotics. Current diagnostic tests are slow, non-specific, and do not reliably identify patients with a high suspicion of sepsis. As a result, they have a limited use in patient management and antibiotic stewardship. Future development of sepsis diagnostics should focus on overcoming these limitations.

Indexed as

antibiotic stewardshipcare pathwaydevelopmentdiagnosticnear-patient testsepsissurvey

Identifiers

PMID33114715
PMCPMC7693654
OpenAlexW3095767903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.